Low-Molecular–Weight Heparin Combined With Insulin Versus Insulin Alone in the Treatment of Hypertriglyceridemic Pancreatitis (LIHTGP Trial)

Bingjun Yu, Wenhua He, Cong He, Nianshuang Li, JiaRong Li, Yin Zhu, Youxiang Chen, Nonghua Lu

Open source

DOI
10.1097/mpa.0000000000001697
Published
2020-10-13
Container
Pancreas
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/mpa.0000000000001697,
  title = {Low-Molecular–Weight Heparin Combined With Insulin Versus Insulin Alone in the Treatment of Hypertriglyceridemic Pancreatitis (LIHTGP Trial)},
  author = {Bingjun Yu and Wenhua He and Cong He and Nianshuang Li and JiaRong Li and Yin Zhu and Youxiang Chen and Nonghua Lu},
  year = {2020},
  journal = {Pancreas},
  doi = {10.1097/mpa.0000000000001697},
  url = {https://doi.org/10.1097/mpa.0000000000001697}
}

RIS

TY  - JOUR
TI  - Low-Molecular–Weight Heparin Combined With Insulin Versus Insulin Alone in the Treatment of Hypertriglyceridemic Pancreatitis (LIHTGP Trial)
AU  - Bingjun Yu
AU  - Wenhua He
AU  - Cong He
AU  - Nianshuang Li
AU  - JiaRong Li
AU  - Yin Zhu
AU  - Youxiang Chen
AU  - Nonghua Lu
PY  - 2020
JO  - Pancreas
DO  - 10.1097/mpa.0000000000001697
UR  - https://doi.org/10.1097/mpa.0000000000001697
ER  - 

APA

Yu, B., He, W., He, C., Li, N., Li, J., Zhu, Y., Chen, Y., & Lu, N. (2020). Low-Molecular–Weight Heparin Combined With Insulin Versus Insulin Alone in the Treatment of Hypertriglyceridemic Pancreatitis (LIHTGP Trial). Pancreas. https://doi.org/10.1097/mpa.0000000000001697

Source records